On Wednesday, Eric Berg of Barclays Capital said reiterated his view that the steep drop in life insurers' share prices over the past two weeks does not point to a looming solvency problem in the industry.
But Wyeth's troubles point out the problem with this strategy, too, because two of its three setbacks--the two announced today--both come from products it licensed from other companies.